- Oxford BioDynamics said it had been granted a patent in India for its EpiSwitch biomarker product.

Counterparts to the patent have already been granted in the US, Europe, China, Japan, Australia, Hong Kong, New Zealand, Singapore and South Africa.

At 1:18pm: [LON:OBD] Oxford Biodynamics Plc share price was +1p at 179.5p

Story provided by